Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-25 | Mr. Nikunj JainInterim CFO and Principal Financial & Accounting Officer | -1,92k | 334,48 | Sale to Issuer | 0,17 | 202,66k | -0,94% |
| 2026-05-25 | Mr. Scott B. WilloughbySenior VP, Chief Legal Officer & Corporate Secretary | -4,04k | 703,47 | Sale to Issuer | 0,17 | 568,62k | -0,70% |
| 2026-05-25 | Dr. Alexander D. MacraeCEO, President & Director | -12,61k | 2,20k | Sale to Issuer | 0,17 | 1,65M | -0,76% |
| 2026-05-25 | Dr. Gregory DavisHead of Research & Technology | -1,63k | 284,11 | Sale to Issuer | 0,17 | 81,02k | -1,97% |
| 2026-05-25 | Dr. Nathalie Dubois-StringfellowSenior VP & Chief Development Officer | -4,04k | 703,47 | Sale to Issuer | 0,17 | 249,98k | -1,59% |
| 2026-04-22 | Dr. Gregory DavisHead of Research & Technology | -69,83k | 17,69k | Verkauf | 0,25 | 77,99k | -47,24% |
| 2026-04-21 | Dr. Nathalie Dubois-StringfellowSenior VP & Chief Development Officer | -345,94k | 89,18k | Verkauf | 0,26 | 242,77k | -58,76% |
| 2026-02-24 | Dr. Nathalie Dubois-StringfellowSenior VP & Chief Development Officer | -14,42k | 6,78k | Sale to Issuer | 0,47 | 588,71k | -2,39% |
| 2026-02-24 | Dr. Alexander D. MacraeCEO, President & Director | -38,93k | 18,31k | Sale to Issuer | 0,47 | 1,63M | -2,34% |
| 2026-02-24 | Mr. Scott B. WilloughbySenior VP, Chief Legal Officer & Corporate Secretary | -14,00k | 6,59k | Sale to Issuer | 0,47 | 561,41k | -2,43% |
| 2026-02-24 | Mr. Nikunj JainInterim CFO and Principal Financial & Accounting Officer | -5,79k | 2,72k | Sale to Issuer | 0,47 | 199,92k | -2,81% |
| 2026-02-24 | Dr. Gregory DavisHead of Research & Technology | -5,95k | 2,80k | Sale to Issuer | 0,47 | 147,82k | -3,87% |
| 2026-01-22 | Mr. Nikunj JainInterim CFO and Principal Financial & Accounting Officer | -7,72k | 3,08k | Sale to Issuer | 0,40 | 180,62k | -4,10% |
| 2026-01-22 | Ms. Prathyusha DuraibabuInsider | -36,68k | 14,62k | Sale to Issuer | 0,40 | 535,03k | -6,42% |
| 2026-01-22 | Mr. Scott B. WilloughbySenior VP, Chief Legal Officer & Corporate Secretary | -36,68k | 14,62k | Sale to Issuer | 0,40 | 541,40k | -6,34% |
| 2026-01-22 | Dr. Alexander D. MacraeCEO, President & Director | -102,95k | 41,03k | Sale to Issuer | 0,40 | 1,56M | -6,20% |
| 2026-01-22 | Dr. Gregory DavisHead of Research & Technology | -7,72k | 3,08k | Sale to Issuer | 0,40 | 139,31k | -5,25% |
| 2026-01-22 | Dr. Nathalie Dubois-StringfellowSenior VP & Chief Development Officer | -36,68k | 14,62k | Sale to Issuer | 0,40 | 568,12k | -6,06% |
| 2025-11-24 | Mr. Nikunj JainInterim CFO and Principal Financial & Accounting Officer | -578,00 | 240,79 | Sale to Issuer | 0,42 | 245,72k | -0,23% |
| 2025-11-24 | Mr. Scott B. WilloughbySenior VP, Chief Legal Officer & Corporate Secretary | -2,04k | 847,78 | Sale to Issuer | 0,42 | 566,95k | -0,36% |
| 2025-11-24 | Dr. Alexander D. MacraeCEO, President & Director | -7,49k | 3,12k | Sale to Issuer | 0,42 | 1,63M | -0,46% |
| 2025-11-24 | Ms. Prathyusha DuraibabuInsider | -2,54k | 1,06k | Sale to Issuer | 0,42 | 560,58k | -0,45% |
| 2025-11-24 | Dr. Nathalie Dubois-StringfellowSenior VP & Chief Development Officer | -2,54k | 1,06k | Sale to Issuer | 0,42 | 583,66k | -0,43% |
| 2025-11-24 | Dr. Gregory DavisHead of Research & Technology | -723,00 | 301,20 | Sale to Issuer | 0,42 | 139,70k | -0,51% |
| 2025-10-22 | Mr. Nikunj JainInterim CFO and Principal Financial & Accounting Officer | -6,71k | 4,43k | Sale to Issuer | 0,66 | 246,30k | -2,65% |
| 2025-10-22 | Mr. Scott B. WilloughbySenior VP, Chief Legal Officer & Corporate Secretary | -44,12k | 29,12k | Sale to Issuer | 0,66 | 487,04k | -8,31% |
| 2025-10-22 | Dr. Alexander D. MacraeCEO, President & Director | -126,95k | 83,79k | Sale to Issuer | 0,66 | 1,40M | -8,30% |
| 2025-10-22 | Dr. Nathalie Dubois-StringfellowSenior VP & Chief Development Officer | -43,74k | 28,87k | Sale to Issuer | 0,66 | 503,27k | -8,00% |
| 2025-10-22 | Ms. Prathyusha DuraibabuInsider | -45,23k | 29,85k | Sale to Issuer | 0,66 | 480,18k | -8,61% |
| 2025-10-22 | Dr. Gregory DavisHead of Research & Technology | -6,71k | 4,43k | Sale to Issuer | 0,66 | 103,25k | -6,10% |
| 2025-08-24 | Dr. Alexander D. MacraeCEO, President & Director | -7,49k | 4,39k | Sale to Issuer | 0,59 | 1,28M | -0,58% |
| 2025-08-24 | Dr. Gregory DavisHead of Research & Technology | -723,00 | 423,89 | Sale to Issuer | 0,59 | 109,95k | -0,65% |
| 2025-08-24 | Mr. Scott B. WilloughbySenior VP, Chief Legal Officer & Corporate Secretary | -1,43k | 840,75 | Sale to Issuer | 0,59 | 442,10k | -0,32% |
| 2025-08-24 | Ms. Prathyusha DuraibabuInsider | -1,79k | 1,05k | Sale to Issuer | 0,59 | 436,34k | -0,41% |
| 2025-08-24 | Dr. Nathalie Dubois-StringfellowSenior VP & Chief Development Officer | -1,79k | 1,05k | Sale to Issuer | 0,59 | 457,94k | -0,39% |
| 2025-07-22 | Dr. Alexander D. MacraeCEO, President & Director | -126,95k | 60,91k | Sale to Issuer | 0,48 | 1,27M | -9,07% |
| 2025-07-22 | Ms. Prathyusha DuraibabuInsider | -31,87k | 15,29k | Sale to Issuer | 0,48 | 433,12k | -6,85% |
| 2025-07-22 | Mr. Scott B. WilloughbySenior VP, Chief Legal Officer & Corporate Secretary | -31,87k | 15,29k | Sale to Issuer | 0,48 | 439,53k | -6,76% |
| 2025-07-22 | Dr. Nathalie Dubois-StringfellowSenior VP & Chief Development Officer | -31,87k | 15,29k | Sale to Issuer | 0,48 | 454,73k | -6,55% |
| 2025-07-22 | Dr. Gregory DavisHead of Research & Technology | -6,71k | 3,22k | Sale to Issuer | 0,48 | 108,65k | -5,81% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
